Zobrazeno 1 - 10
of 76
pro vyhledávání: '"B. A. Armson"'
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0304233 (2024)
[This corrects the article DOI: 10.1371/journal.pone.0227245.].
Externí odkaz:
https://doaj.org/article/17631687e1304849afb4b13808d4dd3a
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0227245 (2020)
OBJECTIVE:To compare effectiveness and safety of oral misoprostol (50 μg every four hours as needed), low dose vaginal misoprostol (25 to 50 μg every six hours as needed), and our established dinoprostone vaginal gel (one to two mg every six hours
Externí odkaz:
https://doaj.org/article/f7e220d10844421694c05b9f5ba3bcf8
Autor:
Olha Lutsiv, Adam Hulman, Christy Woolcott, Joseph Beyene, Lucy Giglia, B. Anthony Armson, Linda Dodds, Binod Neupane, Sarah D. McDonald
Publikováno v:
BMC Pregnancy and Childbirth, Vol 17, Iss 1, Pp 1-12 (2017)
Abstract Background Weight gain during pregnancy has an important impact on maternal and neonatal health. Unlike the Institute of Medicine (IOM) recommendations for weight gain in singleton pregnancies, those for twin gestations are termed “provisi
Externí odkaz:
https://doaj.org/article/7d503f4466d84777a1d0c7f315642443
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 43:1107-1111
Objective To provide guidance on culturally competent contraception counselling that is free of coercion and promotes shared decision-making and patient autonomy. Target population Individuals of reproductive age who seek contraception or counselling
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 43:1112-1117
RESUME Objectif Fournir des recommandations pour que le counseling contraceptif soit adapte a la culture, n'exerce aucune coercition et favorise la prise de decision partagee et l'autonomie de la patiente. Population cible Les personnes en âge de pr
Autor:
Jie Yang, B. Anthony Armson, Rebecca Attenborough, George D. Carson, Orlando da Silva, Maureen Heaman, Patricia Janssen, Phil A. Murphy, Jean Charles Pasquier, Reg Sauve, Peter Von Dadelszen, Mark Walker, Shoo K. Lee, John Andruschak, Sheryll Dale, Kenny Der, Terri Pacheco, Karen Vida, Corrine Frick, Nancy Bott, Lee-Ann Carr, Daniel Bedard, Nicole Robert, Ann Sprague, Maryse Berthiaume, Richard Beaudoin, John Fahey, Irene Gagnon, Phil Murphy, Victoria Allen, Alan Bocking, Jim Bottomley, Emmanuel Bujold, Karen Campbell, Jan Christilaw, Joan Crane, Linda Dodds, Allan Donner, Alexandre Dumont, Susie Dzakpasu, Abigail Forson, Bill Fraser, Anita Gagnon, K.S. Joseph, Michael Klein, Michael Kramer, Martine LaFrance, Karine Lemay, Shiliang Liu, Jean-Marie Moutquin, Carl Nimrod, Robert Platt, Beverley O’Brien, Arne Ohlsson, Shi Wu Wen, Metin Gulmezoghu, Archana Shah, Jose Villar
Publikováno v:
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC. 44(9)
To identify determinants of cesarean delivery (CD) and examine associations between mode of delivery (MOD) and maternal and perinatal outcomes.We conducted a retrospective analysis of a Canadian multicentre birth cohort derived from provincial data c
Publikováno v:
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC. 43(2)
Objective The purpose of this study was to assess compliance with fetal fibronectin (fFN) testing recommendations at a single tertiary care perinatal centre. The secondary objective was to identify factors associated with compliance with these recomm
Autor:
Linda Stirk, Jennifer M. Blake, Jessica Dy, Michael Bow, B. Anthony Armson, Radha Chari, Jon Barrett, Ellen Giesbrecht, R. Douglas Wilson
Publikováno v:
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC. 42(12)
Centres providing maternity care and offering a trial of labour after cesarean must develop and use maternal educational and consent processes that emphasize choice and autonomy related to options for and decisions surrounding vaginal birth after ces
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0227245 (2020)
PLoS ONE
PLoS ONE
Objective To compare effectiveness and safety of oral misoprostol (50 μg every four hours as needed), low dose vaginal misoprostol (25 to 50 μg every six hours as needed), and our established dinoprostone vaginal gel (one to two mg every six hours
Publikováno v:
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC. 42(5)
Sepsis is one of the leading causes of maternal morbidity and mortality. Analyses have determined that delays in early recognition and prompt initiation of appropriate management are key contributing factors in maternal sepsis deaths. Recent cases of